Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Pimecrolimus cream is not effective for treating alopecia areata.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

88% phenol is effective for treating alopecia areata.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Kidney transplant patients often have skin issues, mainly infections.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

TNF-alpha inhibitors can cause various immune-related skin issues.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

People with alopecia areata may have a higher risk of blood clots.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Latanoprost is more effective than minoxidil for treating alopecia areata.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Hair growth and health are influenced by factors like age, environment, and nutrition, and are controlled by various molecular pathways. Red light can promote hair growth, and understanding these processes can help treat hair-related diseases.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.